Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 2
A Phase 2, Open-Label, Single-Arm Trial to Evaluate IV Rademikibart as an Add-on Treatment for Acute Exacerbation in Participants With Asthma and or COPD With Type 2 Inflammation
A Phase 2, open-label, single-arm trial to evaluate IV rademikibart as an add-on treatment for acute exacerbation in participants with asthma or COPD with type…
Asthma AcuteCOPD Exacerbation Acute
Estimated
~$10 – $8,750
Connect Biopharm LLCNCT07705737
Observational
The Reducing Respiratory Emergency Visits Using Implementation Science Interventions Tailored to Setting (REVISITS) Study: A Cluster Randomized Trial
This type II hybrid effectiveness-implementation trial will concurrently study the comparative effectiveness of virtual vs. in-person COPD care transition prog…
COPDCOPD Exacerbation Acute
Estimated
~$10 – $6,250
University of ChicagoNCT05568043
Observational
Neuromuscular Electrical Stimulation (NMES) in Patients Hospitalized With Acute Exacerbation of COPD and/or Community Acquired Pneumonia
In older adults hospitalized for acute medical conditions, immobility, clinical treatments, and the illness itself contribute to physical deconditioning and de…
Community-acquired PneumoniaCOPD Exacerbation Acute
Estimated
~$10 – $6,250
University of VermontNCT05452226